No effect on QT intervals of mipomersen, a 2′-O-methoxyethyl modified antisense oligonucleotide targeting ApoB-100 mRNA, in a phase I dose escalation placebo-controlled study, and confirmed by a thorough QT (tQT) study, in healthy subjects
Crossref DOI link: https://doi.org/10.1007/s00228-015-1992-y
Published Online: 2015-12-09
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yu, Rosie Z.
Gunawan, Rudy
Li, Zhaoyang
Mittleman, Robert S.
Mahmood, Asif
Grundy, John S.
Singleton, Walter
Geary, Richard
Wang, Yanfeng
Text and Data Mining valid from 2015-12-09